Delivery Order SPE2DB24D2101-SPE2DB25FKNGV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.00 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, with an ultimate completion date of July 29, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete transaction under...
- The Defense Logistics Agency awarded a $7,444.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting DLA's ongoing procurement of critical medical supplies for military and federal healthcare systems. The delivery order is issued under...
- The Defense Logistics Agency awarded a $1,301.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a direct delivery of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for $4,292.21 to supply Lantus SoloStar 100 Unit/mL 3mL insulin pens, with completion scheduled for August 6, 2025. The award was issued on August 5, 2025, using firm fixed-price pricing with no set-aside designation, indicating competitive selection. Performance of this delivery order is based in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,119.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin medication, with a completion date of August 1, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively made with no set-aside designation, and performance will...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $414.84 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 unit/ml 3ml Lantus SoloStar insulin injection devices. Performance will take place in Conshohocken, Pennsylvania over a three day period from July 7-10, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $1,039 to supply Lantus SoloStar insulin injection devices to the Defense Logistics Agency Troop Support Medical (DLA). Performance will occur in Conshohocken, Pennsylvania over a one day period in late August 2023. The delivery order was issued under DLA's prime vendor pharmaceutical contracts, which provide medical supplies and...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKNGVDelivery Order
AmerisourceBergen Drug Corp has been awarded a firm fixed-price delivery order valued at $1,278.50 by the Defense Logistics Agency (DLA) for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The award, issued on August 8, 2025, represents a competitive procurement with no set-aside designation and is scheduled for completion by August 11, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's portfolio under its DLA contracts encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains. This particular delivery order for insulin supports ongoing pharmaceutical supply requirements within the military's medical supply chain and reflects the vendor's established capability to meet federal procurement standards through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/8/25 |